|
January 15, 2007
MAJOR AQUACULTURE DRUG APPROVAL FOR 35% PEROX-AIDŽ
35% PEROX-AIDŽ (hydrogen peroxide) was approved on January 11, 2007 for control
of mortality in (1) freshwater-reared finfish eggs due to saprolegniasis, (2)
freshwater-reared salmonids due to bacterial gill disease, and (3)
freshwater-reared coolwater finfish and channel catfish due to external
columnaris disease.
Eka Chemicals, Inc. (Marietta, Georgia), is the sponsor of 35% PEROX-AIDŽ. This
is a very important approval because it is
THE FIRST new waterborne drug approved for a disease claim for any aquatic
species in more than twenty years
THE SECOND aquaculture drug to gain designation under the Minor Use and Minor
Species Animal Health Act which entitles Eka Chemicals, Inc. to seven years of
exclusivity for marketing rights for the approved label claims
THE FIRST new aquaculture drug with an original approval covering multiple label
claims for use in a variety of finfish species
Various entities played a role in this significant achievement. The Upper
Midwest Environmental Sciences Center (UMESC; U.S. Geological Survey, La Crosse,
Wisconsin) developed the data that resulted in the approval for these label
claims and did this with financial support through base funds and the
Federal-State Aquaculture Drug Approval Partnership Project. UMESC (1) wrote the
environmental assessment that completed the environmental safety requirements,
(2) performed target animal safety studies on representative species and their
eggs so that all freshwater-reared finfish and their eggs could be placed on
this or future labels, and (3) conducted laboratory and field effectiveness
studies that resulted in these label claims being approved. Eka Chemicals, Inc.
completed the requirements for manufacturing and worked together with the
National Coordinator for Aquaculture New Animal Drug Applications to (1)
complete the requirements for human food safety, labeling, and all other
information on safety and effectiveness and (2) write the original New Animal
Drug Application.
35%PEROX-AIDŽ is approved with over-the-counter marketing status and has no
requirement for an acceptable daily intake, tolerance, withdrawal time, or
regulatory method. Eka Chemicals Inc. has licensed Western Chemical Inc.
(telephone: 800-283-5292 or 360-384-5898; address: 1269 Lattimore Road,
Ferndale, WA 98248-9424) as the sole distributor of 35%PEROX-AIDŽ.
FDA Center for Veterinary Medicine has indicated that the Low Regulatory
Priority Drug status for hydrogen peroxide is rescinded. Formerly, facilities
could purchase and use most any brand of hydrogen peroxide that was consistent
with FDAs policy. This has changed and the ONLY hydrogen peroxide product that
can legally be purchased and used is 35%PEROX-AIDŽ and it is for the approved
label claims. To use 35%PEROX-AIDŽ to treat additional diseases or additional
species not covered on the current label, licensed veterinarians may be able to
prescribe a legal extra-label use.
|